{
    "nct_id": "NCT05203172",
    "official_title": "ENCORAFENIB/BINIMETINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES",
    "inclusion_criteria": "* Any participant who is receiving study intervention and deriving clinical benefit (as determined by the principal investigator) in an encorafenib/binimetinib Parent Study, with no ongoing NCI CTCAE version 4.03 Grade â‰¥3 or intolerable Grade 2 AEs considered to be related to study treatment.\n* Participants must agree to follow the reproductive criteria as outlined in the applicable Encorafenib/Binimetinib Continuation Sub-Study Protocol.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Any medical reason that, in the opinion of the investigator or sponsor, precludes the participant from inclusion in the study.",
    "miscellaneous_criteria": ""
}